total assets (36,664): $1,262.25T
real estate: $447.61T
commodities (16): $412.58T
companies (20,657): $145.09T
currencies (112): $137.61T
govt bonds (177): $117.06T
cryptos (10,454): $2.29T
Advertise
Sign up

Get the App

Scan with your phone to download. 35,000+ assets in your pocket.

Google Play QR code Google Play
App Store

The global leaderboard of wealth: $1.2 Quadrillion of Assets ranked by Market Cap

Companies

Transgene SA (TRGNF) Discusses Progress in Individualized Neoantigen Therapeutic Vaccines and Expansion into Early-Stage NSCLC Transcript

By seekingalpha.com · · 1 min read
Transgene SA (TRGNF) Discusses Progress in Individualized Neoantigen Therapeutic Vaccines and Expansion into Early-Stage NSCLC Transcript

Transgene SA (TRGNF) Discusses Progress in Individualized Neoantigen Therapeutic Vaccines and Expansion into Early-Stage NSCLC Transcript

Read the full article on seekingalpha.com

Comments 0

No comments yet. Be the first to share your thoughts!

← All News articles
—— As Seen On ——